4//SEC Filing
LIPOSCIENCE INC 4
Accession 0001127602-14-005305
CIK 0001168197operating
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 3:11 PM ET
Size
11.3 KB
Accession
0001127602-14-005305
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
Otvos James D.
EVP, Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2014-02-03−8,730→ 0 totalExercise: $2.50Exp: 2014-02-04→ Common Stock (8,730 underlying) - Exercise/Conversion
Common Stock
2014-02-03$2.50/sh+8,730$21,825→ 484,771 total
Holdings
- 180,167(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The option is fully vested and immediately exercisable. 50% of the shares underlying the option were vested upon issuance on February 4, 2004, with the remainder vesting in 24 equal monthly installments thereafter.
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001168197
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 3:11 PM ET
- Size
- 11.3 KB